.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Teva
Johnson and Johnson
US Army
Fuji
Federal Trade Commission
Dow
Chinese Patent Office
AstraZeneca
Cerilliant

Generated: September 26, 2017

DrugPatentWatch Database Preview

BREVIBLOC IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Brevibloc In Plastic Container, and when can generic versions of Brevibloc In Plastic Container launch?

Brevibloc In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA. There are two patents protecting this drug.

This drug has thirty-three patent family members in twenty-four countries.

The generic ingredient in BREVIBLOC IN PLASTIC CONTAINER is esmolol hydrochloride. There are eight drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.

Summary for Tradename: BREVIBLOC IN PLASTIC CONTAINER

Patents:2
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list50
Clinical Trials: see list469
Patent Applications: see list524
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BREVIBLOC IN PLASTIC CONTAINER at DailyMed

Pharmacology for Tradename: BREVIBLOC IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
BREVIBLOC IN PLASTIC CONTAINER
esmolol hydrochloride
INJECTABLE;INJECTION019386-004Feb 16, 2001RXYesYes► Subscribe► SubscribeY► Subscribe
Baxter Hlthcare
BREVIBLOC IN PLASTIC CONTAINER
esmolol hydrochloride
INJECTABLE;INJECTION019386-004Feb 16, 2001RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: BREVIBLOC IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare
BREVIBLOC IN PLASTIC CONTAINER
esmolol hydrochloride
INJECTABLE;INJECTION019386-004Feb 16, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: BREVIBLOC IN PLASTIC CONTAINER

Country Document Number Estimated Expiration
Canada2410446► Subscribe
Slovenia1368019► Subscribe
Turkey200202557► Subscribe
South Africa200206688► Subscribe
Israel151359► Subscribe
Portugal1368019► Subscribe
China1775207► Subscribe
Japan5778384► Subscribe
Brazil0203517► Subscribe
European Patent Office1368019► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Citi
Johnson and Johnson
Boehringer Ingelheim
QuintilesIMS
Baxter
Covington
Novartis
Accenture
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot